Health care professionals’ perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study

[1]  Emily C. O'Brien,et al.  Shared Decision Making in Atrial Fibrillation: Patient-Reported Involvement in Treatment Decisions. , 2020, European heart journal. Quality of care & clinical outcomes.

[2]  K. Jolly,et al.  Clinicians’ views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis , 2020, PloS one.

[3]  E. Harzheim,et al.  Reasons for encounter in primary health care in Brazil. , 2020, Family practice.

[4]  G. Lip,et al.  The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management. , 2019, European heart journal.

[5]  R. Lopes,et al.  Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting. , 2019, European journal of internal medicine.

[6]  Fares Alahdab,et al.  Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[7]  L. Lynd,et al.  Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study. , 2019, Thrombosis research.

[8]  G. Lip,et al.  Epidemiology of atrial fibrillation , 2018, International journal of clinical practice.

[9]  Deborah M Caldwell,et al.  Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis , 2017, BMJ.

[10]  J. Borges,et al.  Algorithms for monitoring warfarin use: Results from Delphi Method. , 2017, Revista da Associacao Medica Brasileira.

[11]  G. Lip,et al.  Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. , 2017, Thrombosis research.

[12]  Denis Xavier,et al.  The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation. , 2017, Global heart.

[13]  I. Solá,et al.  Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review , 2017, BMC Family Practice.

[14]  Karen Sarmento Costa,et al.  Free access to medicines for the treatment of chronic diseases in Brazil , 2016, Revista de saude publica.

[15]  G. Lip,et al.  Stroke Prevention in Atrial Fibrillation: Focus on Latin America , 2016, Arquivos brasileiros de cardiologia.

[16]  T. Glauser,et al.  The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation , 2016, American journal of medical quality : the official journal of the American College of Medical Quality.

[17]  E. Benjamin,et al.  Atrial fibrillation: prevalence in a large database of primary care patients in Brazil. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  B. Donato,et al.  Cost-Effectiveness of Apixaban Versus Other Noacs And Warfarin, During Hospitalization In The Private Brazilian Health System. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  P. Lotufo.  Stroke is still a neglected disease in Brazil. , 2015, Sao Paulo medical journal = Revista paulista de medicina.

[20]  O. Ramilo,et al.  Abstract O.29: Transcriptional Profiling Discriminates Complete and Incomplete KD from Human Adenovirus , 2015 .

[21]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[22]  Sarah N Hilmer,et al.  Review of epidemiology and management of atrial fibrillation in developing countries. , 2013, International journal of cardiology.

[23]  G. Lip,et al.  Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial , 2013, PloS one.

[24]  D. Lane,et al.  Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. , 2012, Patient education and counseling.

[25]  J. Spertus,et al.  Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians , 2012, Journal of multidisciplinary healthcare.

[26]  J. Segar,et al.  Report from Work Package 2 Qualitative Study of the Healthlines project, research commissioned by the National Institute for Health Research (NIHR). , 2011 .

[27]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[28]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[29]  Gavin T. L. Brown,et al.  Mixing interview and questionnaire methods: Practical problems in aligning data , 2010 .

[30]  I. Benseñor,et al.  Prevalence of electrocardiographic findings in elderly individuals: the Sao Paulo aging & health study. , 2009, Arquivos brasileiros de cardiologia.

[31]  S. Arnon,et al.  Closed and Open-Ended Question Tools in a Telephone Survey About ``The Good Teacher'' , 2009 .

[32]  G. Lip,et al.  Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. , 2006, International journal of cardiology.

[33]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..